Azenta Cash Flow from Financial Activities 2010-2025 | AZTA
Azenta cash flow from financial activities from 2010 to 2025. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
| Azenta Annual Cash Flow Financial (Millions of US $) |
|
|---|---|
| 2024 | $-659 |
| 2023 | $-840 |
| 2022 | $-63 |
| 2021 | $-26 |
| 2020 | $-27 |
| 2019 | $-191 |
| 2018 | $170 |
| 2017 | $-26 |
| 2016 | $-26 |
| 2015 | $-34 |
| 2014 | $-24 |
| 2013 | $-19 |
| 2012 | $-19 |
| 2011 | $-4 |
| 2010 | $1 |
| 2009 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.241B | $0.656B |
| Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the pharmaceutical, biotech, academic and healthcare institutions. Azenta Inc., formerly known as Brooks Automation Inc., is based in CHELMSFORD, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.151B | 48.75 |
| Hims & Hers Health (HIMS) | United States | $11.939B | 124.05 |
| Tempus AI (TEM) | United States | $9.210B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.513B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.137B | 64.64 |
| Privia Health (PRVA) | United States | $2.813B | 192.25 |
| Enovis (ENOV) | United States | $1.861B | 10.37 |
| Clover Health Investments (CLOV) | United States | $1.593B | 0.00 |
| Schrodinger (SDGR) | United States | $1.579B | 0.00 |
| Phreesia (PHR) | United States | $1.385B | 0.00 |
| Omnicell (OMCL) | United States | $1.376B | 24.27 |
| 10x Genomics (TXG) | United States | $1.091B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.650B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.626B | 0.00 |
| Talkspace (TALK) | United States | $0.495B | 148.00 |
| Veradigm (MDRX) | United States | $0.460B | 0.00 |
| Claritev (CTEV) | United States | $0.438B | 0.00 |
| Standard BioTools (LAB) | United States | $0.414B | 0.00 |
| TruBridge (TBRG) | United States | $0.358B | 793.33 |
| Outset Medical (OM) | United States | $0.346B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.267B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.256B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.135B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.132B | 0.00 |
| Pulmonx (LUNG) | United States | $0.119B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.100B | 0.00 |
| CareCloud (CCLD) | United States | $0.087B | 3.31 |
| 111 (YI) | China | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.036B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |